Hyperpigmentation is common in patients with melasma, hyperpigmentation, lentigo senilis and other photoaging conditions. Tretinoin (all-trans retinoic acid) is a prescription medication used to treat acne rosacea , and several other skin conditions. There are two different forms of tretinoin: the hydroquinone form and the fluocinolone form. Both forms of tretiniino have similar chemical structures with differing functional groups. For this reason, both versions can be combined together to create another type of modified release tretinoin called MRET. This article discusses three of the most common uses for MRET tretinoin including its indications oral, dosage form information, potential side effects, clinical trials and research on its safety and efficacy.
OTC MRET Tretinoin topical solution
OTC topical tretinoin is available as a solution and gel. Both forms are available in an 18% concentration and come in a generic bottle. There are no known side effects of topical tretinoin otc, but some patients may experience mild irritation. MRET tretinoin topical solution has been available in the United States since 2007.
Diffusible MRET Tretinoin sustainable result
Diffusible MRET Tretinoin is a new formulation of tretinoin that creates a sustained effect. Its sustained effect means it delivers a steady amount of tretinoin to the skin for a longer period of time. This new formulation has been approved by the FDA and is indicated for the treatment of moderate to severe facial dyschromia and acneiform disorders. Diffusible MRET Tretinoin is available as a solution and gel. Both forms are available in an 18% concentration, and come in generic bottles. This formulation of tretinoin is associated with few side effects, but is not appropriate for all patients.
Treatment of Hyperpigmentation with Modified Release Tretinoin fluocinolone
Modified release tretinoin is typically used to treat hyperpigmentation, including melasma and post-acne hyperpigmentation. The fluocinolone version of tretinoin is recommended for the treatment of acne rosacea and post-inflammatory hyperpigmentation. OTC tretinoin is available as a solution and gel. Both forms are available in an 18% concentration, and come in generic bottles. MRET tretinoin has been available in the United States since 2007.
Raphe Pharmaceutique premium contract manufacturer for pharmaceutical industries
Raphe Pharmaceutique is a specialty pharmaceutical company based in France and Texas. This company is a partner of Novartis in the development of MRET tretinoin. They are the exclusive commercial partner for the sale of MRET tretinoin in Europe. Raphe Pharmaceutique has developed a new type of tretinoin called fluocinolone tretinoin. This is a modified release version of tretinoin that creates a longer-lasting effect. This new version is intended for the treatment of acne rosacea and hyperpigmentation. Diffusible MRET Tretinoin sustainable result MRET is a new type of tretinoin that creates a sustained effect. The concentration of tretinoin and the release pattern of this medication differs from other types of topical tretinoin. A sustained effect means that the medication is released over a longer period of time. This can have the advantage of not having to use the medication as often. Furthermore, it can also reduce the chances of side effects.